ClosedSuppliesEuropeanOnderhandeling zonder bekendmakingGreen

Cancellation DKT-vaccines - RIVM & GSK

Rijksinstituut voor Volksgezondheid en Milieu (RIVM) · Onderhandeling zonder bekendmaking · 1 lots · 371463
Type
Supplies
33651600
Estimated value
€ 5,00M
estimated
To deadline
Ongoing
Knock-outs
n/a
exclusion grounds
Award basis
Best price-quality ratio
Assess manuallyconfidence low

The procurement report concerns a closed supply procedure without disclosure for DKT-vaccines, conducted by the Rijksinstituut voor Volksgezondheid en Milieu (RIVM). The procedure falls under CPV code 33651600 and is specifically aimed at the supply of vaccines. The publication date is 20 March 2025, without a specified deadline or known value.

Supplies · Onderhandeling zonder bekendmaking · European procedure

Sustainability countsEuropean
Contract type
Supplies
Onderhandeling zonder bekendmaking
Estimated value
€5,000,000
estimated value
Submission deadline
Ongoing
Scope
European
European procedure
Lots
1
1 lots
Main CPV code
Location
Netherlands
CharacteristicsCPV 33SuppliesEU tenderGreen / SPP

01What is being requested

The procurement report concerns a closed supply procedure without disclosure for DKT-vaccines, conducted by the Rijksinstituut voor Volksgezondheid en Milieu (RIVM). The procedure falls under CPV code 33651600 and is specifically aimed at the supply of vaccines. The publication date is 20 March 2025, without a specified deadline or known value.

Supply of vaccines

33651600€ 5,00MSupplies
11 lot: supply of DTaP-vaccines€5,000,000

02Exclusion grounds

Exclusion grounds — consult the ESPD
  • No specific exclusion grounds were extracted. In a European tender, the mandatory and discretionary grounds of art. 2.86/2.87 of the Dutch Procurement Act almost always apply — check the European Single Procurement Document (ESPD).

03Value in context

€5,000,000

04Likely competitors

#Likely bidderFitWins
1GlaxoSmithKline B.V.SME78
2Siemens Healthineers Nederland B.V.SME7613×
3Mediost B.V.SME7414×
4King Nederland B.V.SME7210×
5Fuego Tiel B.V.SME71
6Genzyme Europe B.VSME70

05Legal themes that may be relevant here

06Frequently asked questions

What is the purpose of this supply?
The contract concerns the supply of DTaP-vaccines for the RVP vaccination schedule 2025. This is necessary for the vaccination of 5-year-olds, where the 2021 birth cohort is the starting cohort for this change.
From when must the DTaP-vaccines be available?
The DTaP-vaccines must be available to the implementers for the vaccination of the target group (5-year-olds) from January 2026 onwards.
Which criteria are used during the assessment?
Sustainability criteria are applied in this tender.

Automatically compiled from the official tender data and documents.

07Estimated value versus the market

p25
€ 317K
median
€ 892K
p75
€ 3,3 mln
€ 5,0 mln

Gegunde waarden in CPV 33 · leveringen n=528